Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX) Insider Trading
Directors, officers and holders of more than 10% of DFTX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 52 transactions on file: 0 with code P, 14 with code S and 36 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Wiley Matthew T. | Chief Commercial Officer | S Sale | 3,097 | $36.57 | $113,257 |
| Sep 25, 2026 | Barrow Robert | Chief Executive Officer | S Sale | 31,550 | $36.57 | $1,153,784 |
| Sep 25, 2026 | Karlin Daniel | Chief Medical Officer | S Sale | 10,853 | $36.57 | $396,894 |
| Sep 25, 2026 | Roberts Brandi | Chief Financial Officer | S Sale | 3,377 | $36.57 | $123,497 |
| Sep 25, 2026 | Sullivan Mark | Chief Legal Officer | S Sale | 14,051 | $36.57 | $513,845 |
| Sep 18, 2026 | Krebs Andreas | Director | M Exercise | 1,629 | $35.52 | $57,862 |
| Sep 18, 2026 | Krebs Andreas | Director | M Exercise | 1,629 | Not measured | Not measured |
| Sep 18, 2026 | Vallone Carol A | Director | M Exercise | 1,086 | Not measured | Not measured |
| Sep 18, 2026 | Vallone Carol A | Director | M Exercise | 1,086 | $35.52 | $38,575 |
| Sep 14, 2026 | Wiley Matthew T. | Chief Commercial Officer | A Award | 125,000 | Not measured | Not measured |
| Sep 14, 2026 | Barrow Robert | Chief Executive Officer | A Award | 750,000 | Not measured | Not measured |
| Sep 14, 2026 | Roberts Brandi | Chief Financial Officer | A Award | 125,000 | Not measured | Not measured |
| Sep 14, 2026 | Sullivan Mark | Chief Legal Officer | A Award | 125,000 | Not measured | Not measured |
| Sep 14, 2026 | Karlin Daniel | Chief Medical Officer | A Award | 200,000 | Not measured | Not measured |
| Sep 3, 2026 | Barrow Robert | Chief Executive Officer | S Sale | 19,023 | $37.94 | $721,733 |
| Sep 2, 2026 | Barrow Robert | Chief Executive Officer | A Award | 40,000 | Not measured | Not measured |
| Aug 12, 2026 | Sullivan Mark | Chief Legal Officer | A Award | 62,500 | Not measured | Not measured |
| Aug 12, 2026 | Barrow Robert | Chief Executive Officer | A Award | 375,000 | Not measured | Not measured |
| Aug 12, 2026 | Karlin Daniel | Chief Medical Officer | A Award | 100,000 | Not measured | Not measured |
| Aug 12, 2026 | Wiley Matthew T. | Chief Commercial Officer | A Award | 62,500 | Not measured | Not measured |
| Aug 12, 2026 | Roberts Brandi | Chief Financial Officer | A Award | 62,500 | Not measured | Not measured |
| Jun 25, 2026 | Barrow Robert | Chief Executive Officer | S Sale | 29,208 | $45.03 | $1,315,236 |
| Jun 25, 2026 | Karlin Daniel | Chief Medical Officer | S Sale | 10,035 | $45.03 | $451,876 |
| Jun 25, 2026 | Wiley Matthew T. | Chief Commercial Officer | S Sale | 2,867 | $45.03 | $129,101 |
| Jun 25, 2026 | Sullivan Mark | Chief Legal Officer | S Sale | 13,008 | $45.03 | $585,750 |
| Jun 25, 2026 | Roberts Brandi | Chief Financial Officer | S Sale | 3,013 | $45.03 | $135,675 |
| Jun 22, 2026 | Karlin Daniel | Chief Medical Officer | A Award | 100,000 | Not measured | Not measured |
| Jun 22, 2026 | Sullivan Mark | Chief Legal Officer | A Award | 62,500 | Not measured | Not measured |
| Jun 22, 2026 | Wiley Matthew T. | Chief Commercial Officer | A Award | 62,500 | Not measured | Not measured |
| Jun 22, 2026 | Barrow Robert | Chief Executive Officer | A Award | 375,000 | Not measured | Not measured |
| Jun 22, 2026 | Roberts Brandi | Chief Financial Officer | A Award | 62,500 | Not measured | Not measured |
| Jun 11, 2026 | Krebs Andreas | Director | A Award | 4,666 | Not measured | Not measured |
| Jun 11, 2026 | Vallone Carol A | Director | A Award | 4,666 | Not measured | Not measured |
| Jun 11, 2026 | GRYSKA DAVID W | Director | A Award | 4,666 | Not measured | Not measured |
| Jun 11, 2026 | CRYSTAL ROGER | Director | A Award | 4,666 | Not measured | Not measured |
| Jun 11, 2026 | Vallone Carol A | Director | A Award | 19,188 | Not measured | Not measured |
| Jun 11, 2026 | Adsett Roger | Director | A Award | 14,620 | Not measured | Not measured |
| Jun 11, 2026 | Bruhn Suzanne Louise | Director | A Award | 19,188 | Not measured | Not measured |
| Jun 11, 2026 | Bruhn Suzanne Louise | Director | A Award | 4,666 | Not measured | Not measured |
| Jun 11, 2026 | Adsett Roger | Director | A Award | 3,555 | Not measured | Not measured |
| Jun 11, 2026 | CRYSTAL ROGER | Director | A Award | 19,188 | Not measured | Not measured |
| Jun 11, 2026 | GRYSKA DAVID W | Director | A Award | 19,188 | Not measured | Not measured |
| Jun 11, 2026 | Krebs Andreas | Director | A Award | 19,188 | Not measured | Not measured |
| Mar 25, 2026 | Karlin Daniel | Chief Medical Officer | S Sale | 8,018 | $18.47 | $148,092 |
| Mar 25, 2026 | Sullivan Mark | Chief Legal Officer | S Sale | 10,702 | $18.47 | $197,666 |
| Mar 25, 2026 | Barrow Robert | Chief Executive Officer | S Sale | 24,431 | $18.47 | $451,241 |
| Feb 3, 2026 | Wiley Matthew T. | Chief Commercial Officer | A Award | 115,000 | Not measured | Not measured |
| Feb 3, 2026 | Sullivan Mark | Chief Legal Officer | A Award | 125,000 | Not measured | Not measured |
| Feb 3, 2026 | Roberts Brandi | Chief Financial Officer | A Award | 150,000 | Not measured | Not measured |
| Feb 3, 2026 | Barrow Robert | Chief Executive Officer | A Award | 320,000 | Not measured | Not measured |
The full Form 4 history is on the DFTX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.